We are pleased to invite you to Connext 2021 - The Pharma Software Summit by Werum Solutions! This four-day-conference will replace our yearly PAS-X User Group Meeting and the PFU (PAS-X for Us) Meeting all under one virtual roof.
Connext brings together pharma, biotech and cell & gene companies who use Werum PAS-X MES as well as those who are interested in the use of manufacturing IT and manufacturing intelligence to digitize their production. For the first time, our meeting will take place as a virtual online event under the joint Körber brand. Accommodations have been made for different time zones in Asia, Europe and the US.
Be part of the biggest Pharma Software Summit from 2-5 March 2021!
Under the theme "Elevating your business. Together.", the Connext, the Pharma Software Summit by Werum Solutions, offers a comprehensive program of best-practice user presentations, workshops, product demonstrations, panel discussions and online networking opportunities to get you connected.
"We expect pharma and biotech experts from all over the world," says Jens Woehlbier, Chief Executive Officer (CEO), Körber Business Area Pharma. "Together, they form the world's largest pharma software community! Join us, connect yourself and learn more about our Körber software solutions to digitize your pharma, biotech and cell & gene factory."
How has the COVID-19 pandemic affected pharmaceutical and biotech production – and what role do Manufacturing Execution Systems (MES) play in this?
These and other related questions will be discussed by Rod Hoffman (AstraZeneca), Dr. Alfred Merz and Heike Röder (Bayer), Claus Kappler (Novartis), Johann Wieser (Takeda), and Kai Vogt (Vetter Pharma) under the expert moderation of Zinaid Dzinovic (Körber).
Digitization and the remote operations, that it enables, not only ensure stability and business continuity. They also ensure the right digital setup to anticipate additional challenges in the future.
Implementing Manufacturing Execution Systems (MES) and Electronic Batch Recording improves scalability, productivity and compliance in pharma and biotech plants. The last few years have seen a consistent shift to cloud-hosted systems, especially in emerging cell & gene therapy manufacturing.
During our panel on “MES in the cloud”, Christopher Kopinski (Amazon Web Services), Stephen Fleming (Johnson & Johnson), Dr. Martin Sternitzke (Körber) and Kawa Chiu (Lyell), moderated by Welf Ludwig (Körber), will discuss the advantages of cloud-hosted solutions.